Huaan Securities maintains the buy rating of Teyi Pharmaceutical: Net profit growth after deducting non-return to the parent exceeds expectations, and characteristic brands are worth looking forward to – yqqlm

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002728 Huaan Securities Teyi Pharmaceutical Group Management Research, Development Pharmaceutical Paper, Packaging Product Securities Epidemic Medicine

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Huaan Securities maintains the buy rating of Teyi Pharmaceutical: Net profit growth after deducting non-return to the parent exceeds expectations, and characteristic brands are worth looking forward to – yqqlm